Commercial Partners
Commercial Partners 2021
Adare Pharmaceuticals
Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s proprietary technology platforms specialize in ODT, taste masking and customized drug release.
With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by partners in more than 100 countries globally.
To learn more, please visit us at www.AdarePharma.com
With Orbis Biosciences acquisition Adare has now 3 technologies for taste-masked and controlled release multi-particulates. The technologies allow creation of sustained release oral suspensions and injectables.
Armor Pharma
ARMOR PHARMA manufactures and markets 3 ranges of pharmaceutical grade lactose for all your applications:
- ARMOR PHARMA™ lactose monohydrate: sieved & milled lactose for sachets, tablets and capsules formulation
- EXCIPRESS™: lactose for Direct Compression
- EXCIPURE™: lactose for Dry powder Inhalation
ARMOR PHARMA's ambition is to design solutions that best support customer's development. Our positioning reflects this philosophy, centred on a question that makes sense: "How would you like your lactose?"
For more information, or to tell us how you would like your lactose:
BASF
Focusing On Your Formulation Needs
BASF produces excipients and active ingredients of outstanding quality and performance. With our unique expertise in polymer chemistry, our research & development capabilities and our clear commitment to developing excipients, BASF has continuously created solutions that contribute to your success and to more efficient pharmaceuticals. We deliver value added functional solutions to your formulation challenges by leveraging our expertise in delivery systems and related technologies. Our team of experienced industry specialists support you in developing effective, reliable formulations – giving you a vital advantage in a highly competitive market.
Our Platforms – Your Access To BASFs Solution Offer
BASF has been committed to the pharmaceutical industry since we introduced our original Kollidon® in the early 20th century. Since then we have continuously expanded our solution offer. Today we solve unmet formulation needs and offer intelligent solutions for today and tomorrow's challenges in drug formulation. Our four dedicated solution platforms based on current pharmaceutical market needs help you to find what you are looking for – faster than ever before. We can help with formulation challenges related to Instant and Modified Release, Solubilization, Skin Delivery, Softgels and Biologic Solutions
BENEO
galenIQ™ - The filler-binder excipient that makes medicine taste better
BENEO, a division of the Südzucker Group, offers galenIQTM (Isomalt Ph.Eur., BP, USP-NF, JP), which is a water-soluble pharmaceutical excipient filler-binder.
galenIQ™ combines a multitude of outstanding characteristics, suitable for a wide range of pharmaceutical applications. In fact, it also has a sweetness and taste profile that is very similar to sucrose and therefore it is frequently used to improve the palatability of bitter-tasting active pharmaceutical ingredients (APIs), plant extracts and probiotics. galenIQ™ is non-cariogenic and shows a low glycaemic index which makes it the optimal choice for the formulation of a broad variety of dosage forms, such as chewable tablets, compressed lozenges, oro-dispersible mini-tablets, effervescents, sachets, and cough syrups.
BENEO is a member of the International Pharmaceutical Excipients Council (IPEC) and produces galenIQ™ under GMP conditions for pharmaceutical products.
www.BENEO.com
www.galenIQ.com
Catalent
Catalent is the Number One global leader in drug formulation development. From our robust network of expertise and innovative technologies, Catalent offers the most comprehensive early-phase drug development solutions.
Specializing in analytical and bioavailability enhancement, from preformulation to fully integrated solutions, Catalent helps get your drug to market faster.
Catalent’s integrated solutions, OptiForm® Solution Suite and OptiForm® Total Supply, aide in accelerating your molecule from candidate to clinic.
Our capabilities in spray drying, hot melt extrusion, modified-release, and roller compaction provide our customers with our broad-based expertise in working with challenging compounds to find the optimal dosage form to suit each project.
DFE Pharma
DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation. Our portfolio consists of filler/binders (Lactose, Microcrystalline Cellulose, Starches), superdisintegrants (Croscarmellose Sodium and Sodium Starch Glycolate) and carriers for inhalation (Lactose). Please visit dfepharma.com
Foster Delivery Science
Foster Delivery Science focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, clinical trial material and ready for GMP manufacturing.
Halo Labs
Halo Labs knows particles. The HORIZON, our flagship product, detects, counts and characterizes subvisible particles. A simple, plate-based approach enables low-volume (25 µL), high-throughput (96 samples) particle imaging and analysis at any stage of the biologics workflow from developability assessment through formulation and quality control.
Lonza Pharma & Biotech
At Lonza Pharma & Biotech, we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome, at the time when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just current, but also future challenges. Together, we can bring your next medicine to life.
LTS Lohmann
LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch. The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA. More than 3,000 patents reinforce the top position of LTS group in development of its technologies. LTS Lohmann services include: Feasibility studies Full product development Clinical studies phase I-IV Scale-up and process development Commercial manufacturing For transdermal therapeutic systems, topical patches and oral thin films (OTF)
MedPharm
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established R&D centres in the USA and UK and has its global HQ in Guildford, UK.
Munit SA
MUNIT is a consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.
In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership in the micronization sector.
MUNIT is your access point to JETPHARMAs and MICROCHEMs services:
- Jet- , Pin- and Hammer milling
- Cryogenic Micronization
- Co- micronization
- Sieving, Blending, De-Lumping
- Technical trials, DoE Studies, Process development and validation
- QbD
- PSD analysis etc.
With MUNITs lean organisation, its welcoming and customer orientated attitude, we are able to guarantee best service, high efficiency and punctuality to our customers worldwide.
Pfanstiehl Inc.
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Ribose for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
Pion
Pion is a science-based company providing innovative technology, solutions, support and scientific expertise to the drug development industry. Pion empowers the pharmaceutical research community to use trusted data for the development of new and unique products that make a difference to people’s lives.
For drug development scientists requiring trusted data, we provide novel in-vitro tools that promote quicker, more informed decision-making. Unlike conventional techniques, that were never designed for today’s science, Pion technologies lead to more predictable in-vivo outcomes.
Drug development can be a complex, multi-faceted challenge – so finding effective scientific support can be critical to making progress. More and more organizations are turning to Pion Analytical Services, for the tests, assays, analysis and interpretation required at all the key phases of drug development. As well as offering standardised assays our Scientists would love to talk to you about any other experiments you would like to run.
Quotient Sciences
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Roquette
Roquette is a global leader in plant-based ingredients and a pioneer of new vegetal proteins. In collaboration with its customers and partners, the Group addresses current and future societal challenges by unlocking the potential of Nature to offer the best ingredients for Food, Nutrition and Health markets. Each of these ingredients responds to unique and essential needs, and they enable healthier lifestyles. Thanks to a constant drive for innovation and a long-term vision, the Group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories. Roquette currently operates in over 100 countries and employs 8,600 people worldwide.
Schrödinger
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions that accelerate and increase the efficiency of drug discovery and materials design. Schrödinger has a growing pipeline of early-stage assets and has co-founded leading biotech companies, including Nimbus Therapeutics and Morphic Therapeutic. In addition, the company has deep partnerships and collaborations in such fields as biotechnology, pharmaceuticals, chemicals, and electronics. Through significant long-term investments in basic research, Schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. Founded in 1990, Schrödinger has nearly 400 employees and operations in the United States, Europe, Japan, and India, as well as business partners in China and Korea.
ShinEtsu Tylose GmbH & Co KG
Shin-Etsu PFMD is the distribution organization of Shin-Etsu Chemical Co., Ltd. Japan and SE Tylose, Wiesbaden Germany and is registered in Wiesbaden. It is located at the Industrial Park Kalle-Albert in Wiesbaden. Together with our distributors, we are the exclusive business partners for our customers and multi national key accounts in the pharmaceutical- and the food industry. SE PFMD manages a regional, centralized warehouse for all products to be able to supply the customers in Europe on short-term base whenever necessary. SE PFMD will manage logistic for customers in other regions independent from Shin-Etsu´s production sites. For our pharma customers we offer with our technical application lab the possibility to optimize their processes if required. Our products are covering a very wide range of applications and they fully comply with FDA, USP/NF, JP and EP requirements. Pharmaceutical Excipients: Cellulose ether excipient is a pharmacologically inactive substance used as a carrier for the active ingredients in medication. PHARMACOAT® – Water-Soluble Film Coating Agent METOLOSE® – Binder and Thickening Agent METOLOSE® SR – Sustained release agent for hydrophilic matrix system L-HPC – Disintegrant with Binding Properties, Multifunctional Excipient HPMCP – Enteric Coating Agent Shin-Etsu AQOAT® – Enteric Coating Agent, Solid Dispersion Polymer Tylopur® – Low- and high viscosity Hypromellose